I. The Standard Dosage of AtremoPlus To establish a standardized method, it was essential to ensure reliable and consistent dosing. That’s why we implemented a process to standardize AtremoPlus in terms of L-Dopa content.While nature offers many advantages, including excellent…
I.The Pharmaceutical Industry’s Approach to Stem Cells For decades, people with Parkinson’s have been waiting for solutions that go beyond current treatments, which alleviate symptoms without stopping the disease’s progression. It is well known that these symptomatic treatments lose effectiveness…
What role do emotions and stress play in the pathogenesis of Parkinson? In this newsletter, we explore a frequently overlooked aspect in the study of Parkinson’s disease: the potential links between emotions, trauma, and the pathogenesis of the disease. While…
Noradrenaline: As Important as L-Dopa and Carbidopa in the Fight Against Parkinson’s? In the field of Parkinson’s disease research, almost all attention has long focused on a single neurotransmitter: dopamine. As you know, AtremoPlus contains natural L-Dopa, the main ingredient necessary…
In our latest newsletter, we discussed our commitment to understanding the mechanisms of action and measuring key parameters and biomarkers. This approach allows us to quantify the concrete impact on motor and cognitive performance, with observable effects shortly after initial intake. In…
Why this significant reduction in Tremors? In this newsletter part 2 tremors, we will delve deeper into this important topic of tremors. We are delighted to report that in our recent survey, the two groups most affected by “very severe”…
A significant reduction in Tremors: In our latest newsletter, we discussed involuntary movements, often abrupt, known as dyskinesias. In this edition, we’ll delve into another uncontrollable phenomenon in Parkinson’s disease: tremors. Tremors are one of the hallmark symptoms of Parkinson’s…
A significant reduction in Dyskinesia: In this new newsletter, we will address another delicate topic related to Parkinson’s disease: dyskinesias. In previous bulletins, we have examined the phenomenon of voluntary movement blockage, called freezing, as well as “off periods,” where…
Less Freezing / Motor Blockage In this newsletter, we will delve deeper into the theme of “freezing”, also known as “motor blockage”. Freezing is characterized by temporary periods where voluntary movements are blocked. In the case of “cognitive freezing”, the thinking…
A significant reduction in the phenomenon of freezing/motor blockage In this newsletter, we will explore the well-known phenomenon in people with Parkinson’s disease: the freezing. This disorder, also known as “motor blockage”, is characterized by temporary periods of voluntary movement…